Fairvalue-Calculator Fairvalue-Calculator
EN DE

DIO Corporation (039840) Fair Value & Analysis

Healthcare · KR · Market cap 174B KRW

Price12,630 KRW
Fair Value18,626 KRW
Upside+47.5%
Quality95/100
Evidence: Medium Range 13,329 KRW – 23,923 KRW

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

DIO Corporation (039840) currently trades at 12,630 KRW, while our model-based Fair Value estimate is 18,626 KRW — implying the stock looks roughly 47.5% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

DIO Corporation manufactures and sells dental implants in South Korea and internationally. The company offers UFII implant internal submerged and no-submerged systems, FTN implant external systems, protem implants, and UV active implant systems. It also provides digital dental implant solutions; and dental products and cardiovascular medical devices. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is DIO Corporation (039840) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 18,626 KRW versus a price of 12,630 KRW — about +47% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 039840?
Our 21-model fair value for DIO Corporation is 18,626 KRW (as of Jun 24, 2026), built from audited fundamentals. The current price is 12,630 KRW.
What is the quality score of 039840?
DIO Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.